Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients
about
Transcriptome analysis of Ginkgo biloba kernelsApplication of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in ratsMolecular mechanisms underlying the cholesterol-lowering effect of Ginkgo biloba extract in hepatocytes: a comparative study with lovastatinEGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes.Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregationGinkgo biloba extract (GbE) enhances the anti-atherogenic effect of cilostazol by inhibiting ROS generation.Functional genomics of a living fossil tree, Ginkgo, based on next-generation sequencing technology.A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin.Ginkgo suppresses atherosclerosis through downregulating the expression of connexin 43 in rabbits.EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1.Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases.The effect of EGB on proliferation of gastric carcinoma SGC7901 cells.Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: a network meta-analysis of randomized controlled trials.A new ginkgo fresh plant extract increases microcirculation and radical scavenging activity in elderly patients.
P2860
Q28606801-991555CC-1289-445B-BEC4-8E78C96B0E28Q28656449-3370A899-5049-48C5-A8A9-18BF706188FFQ33554965-1876E243-5D27-459F-AB9F-E676EDD4D55CQ33926875-A8FE96ED-1051-4CFC-8866-FEBA7D5988A3Q35220485-ABBF4CB4-89FF-4836-BB5E-D86F97DE54F1Q36005058-E5B6131C-AC47-4729-8356-1766D0AB75ACQ38501170-B4DAEEA1-B798-4442-92D8-F8E3919259CAQ38630265-303CDF00-4AF8-4A3E-B564-795B869C8B07Q40549729-3E405F67-B45B-415B-8FED-7708A4F93534Q42975787-52078A3E-595F-47BC-ACDD-0BA669F5873EQ49265078-2FFF30CC-1BAB-4FD0-921D-0307D3AD5CCCQ52908107-34DE213C-619A-40C7-AFE7-ADFAE7821FBBQ55032619-ECC9C7B5-2C35-47D7-B87F-9ED08998EFFBQ55055269-B32C44FD-BD78-4B13-BBA5-D056E0F7449B
P2860
Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Reduction of atherosclerotic n ...... diovascular high-risk patients
@ast
Reduction of atherosclerotic n ...... diovascular high-risk patients
@en
Reduction of atherosclerotic n ...... diovascular high-risk patients
@nl
type
label
Reduction of atherosclerotic n ...... diovascular high-risk patients
@ast
Reduction of atherosclerotic n ...... diovascular high-risk patients
@en
Reduction of atherosclerotic n ...... diovascular high-risk patients
@nl
prefLabel
Reduction of atherosclerotic n ...... diovascular high-risk patients
@ast
Reduction of atherosclerotic n ...... diovascular high-risk patients
@en
Reduction of atherosclerotic n ...... diovascular high-risk patients
@nl
P2093
P921
P1433
P1476
Reduction of atherosclerotic n ...... diovascular high-risk patients
@en
P2093
L Ringstad
M Malmsten
M Rodríguez
P304
P356
10.1016/J.ATHEROSCLEROSIS.2007.02.021
P407
P577
2007-06-01T00:00:00Z